Semaglutide (GLP‐1 receptor agonist) stimulates browning on subcutaneous fat adipocytes and mitigates inflammation and endoplasmic reticulum stress in visceral fat adipocytes of obese mice
Citations
78
Subjects
Non-Human
Review papers consolidate the current state of knowledge on a topic. While they don't present new experimental data, they offer valuable context and identify gaps in existing research.
This research contributes to the growing body of evidence on semaglutide. Understanding the mechanisms and clinical applications of these peptides is an active area of investigation.
Citation
F. Martins, T. S. Marinho, L. E. Cardoso et al.. (2022). Semaglutide (GLP‐1 receptor agonist) stimulates browning on subcutaneous fat adipocytes and mitigates inflammation and endoplasmic reticulum stress in visceral fat adipocytes of obese mice. Cell Biochemistry and Function. https://doi.org/10.1002/cbf.3751
This content is derived from peer-reviewed research for educational purposes only. It does not constitute medical advice. Always consult a qualified healthcare provider before using any peptide-based therapy.